Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cipla signs licensing pact with MultiG for COVID-19 rapid antibody test kit
'Covi-G' has been commercialised in 20+ countries, with sensitivity and specificity exceeding 92 per cent, informs company
CoronaVac from Sinovac triggers quick immune response
The Sinovac findings came from results in Phase I and Phase II clinical trials in China involving over 700 participants
NSRT to conduct phase II trials of Eflornithine to treat COVID-19
The trials will be conducted in four cities namely; Delhi, Lucknow, Pune, and Bengaluru and the company aims to complete the…
EMA begins rolling review of Moderna’s COVID-19 vaccine candidate
Moderna also announced a supply agreement with the UK government to supply mRNA-1273, if approved for use by MHRA
Foxx Life Sciences to open Asia headquarters in Medchal, Hyderabad
The new facility will have warehouse inventory and manufacturing for the APAC region
India, China may start producing Sputnik V vaccine: Putin
Putin also proposed that the creation of a vaccine research centre for BRICS countries be sped up
T2D market will grow from a total of $48.1bn sales in 2019 to $91.9 bn in 2029
T2D market growth factors are increasing diagnosed prevalence of disease and the emergence of novel pipeline agents
National Pharmacy Week 2020, organised by IPA commences
Inaugurated by Prof Bejon Misra and Yogita Singh, the theme of the NPW this year is 'Pharmacists: Frontline Health Professionals'
Pfizer to commence pilot delivery programme for COVID-19 vaccine in the US
It has picked four states i.e. Rhode Island, Texas, New Mexico, and Tennessee for the programme
Inovio to start mid-stage trials of its COVID-19 vaccine
The US FDA had put Phase 3 of the mid-to-late stage trial on hold, and sought more information, including details on a delivery…